Proteome Sciences' 2011 Revenues Climb Sharply | GenomeWeb

NEW YORK (GenomeWeb News) – Proteome Sciences preliminarily reported Tuesday that its revenues more than doubled year over year for full-year 2011.

For the year ended Dec. 31, 2011, the UK company recorded revenues of £1.0 million ($1.6 million), up from £450,088 for full-year 2010. The 2010 figure excludes the exceptional £9.5 million in income from the Sanofi-Aventis warranty claim settlement, Proteome Sciences said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.